Respiratory

Thirdhand smoke exposure poses a health threat to children. New research examines the factors that may lead to some children having more exposure than others.

Decreased lung function may be a result of a preterm delivery. Does treatment with long-acting β2 agonists (LABA) plus inhaled corticosteroids perform better than just inhaled corticosteroids to improve lung function in affected children?

Used to treat asthma in adolescents and adults, a clinical trial examines whether it would be effective in treating uncontrolled asthma in younger children.

In spite of the availability of effective treatments, asthma is not always well controlled among teenagers. An investigation examines whether using peers to helm education efforts can lead to improved outcomes.

The jury is out on whether testing or exposure better explains the unseasonable surge of respiratory syncytial virus.

The US Food and Drug Administration has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.

The National Institutes of Health announced the launch of a long-term study into the long ranging outcomes of recovering from COVID-19 in children, adolescents, and young adults.

An investigation examines whether safety communications from the US Food and Drug Administration (FDA) in 2017 and 2018 led to reductions in the prescription of cough and cold medications with codeine and hydrocodone.

Dr. Tan shares her must-reads from the October issue.

Between the subtle differences between viral and bacterial pneumonia and the demands or beliefs of certain parents can make an accurate diagnosis of community-acquired pneumonia (CAP) more difficult.

In cases of poorly controlled disease, even with good medication adherence, it might make sense to turn to biologics. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition covered biologics available for treating asthma and allergic skin disease.

At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Maria Rahmandar, MD, FAAP, reviews issues surrounding teen e-cigarette use in schools, along with methods to help teens quit.

Nonadherence to medication is a frustrating element of treating patients, particularly those with chronic conditions. A session at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition offers insight into the common causes behind it and how to improve adherence.

The winter season of respiratory diseases is nearly here. Knowing how to manage community-acquired pneumonia is essential.

The pandemic has increased awareness for many infectious diseases, including croup.

With COVID-19 still at large, pediatricians should prepare for a tough allergy season.

Merck has released promising topline results from their study of VAXNEUVANCE™, a 15-valent pneumococcal conjugate vaccine, in infants.

Vaping has led to some serious erosion in the campaign to end adolescent nicotine use. What drives vaping cessation in this population?

Climate change means more than stronger, more ferocious weather and hard-to-contain wildfires. Here's what it means for allergies.

Just because the weather cools down in the Fall months, doesn't mean that respiratory allergies are done. Here's a look at some of the best respiratory allergy remedies.

Respiratory syncytial virus (RSV) usually has a similar season as influenza. However, face masks and social distancing have altered the timeline. The American Academy of Pediatrics (AAP) has released guidance for using palivizumab during this interseason period.

A previously healthy 16-year-old female patient presents with intermittent pleuritic chest pain and shortness of breath. The night before her symptoms started, she hit her chest on a door after a "fainting" episode.

Cough is a common reason for pediatric visits. When should bronchitis be on the diagnostic radar?

Vitamin D supplement use has been suggested to improve a variety of health outcomes. A report investigates whether it can aid in providing better asthma control.

Intravenous (IV) magnesium sulfate is recommended for treating refractory pediatric asthma, but is it linked to consequent hospitalization?

A report offers the first epidemiological data that applied new criteria for bronchopulmonary dysplasia.

A report examines the trends in bronchiolitis, which is a common respiratory illness in children, including hospitalization needs.

New recommendations and treatment options for this common condition in children.

Social and family factors can have a large impact on a child’s health outcomes. A report examines how they can impact respiratory syncytial virus hospitalization.

The push to responsibly use antibiotics has led to shorter treatment courses when the efficacy is similar to a longer one. A study examines whether shorter courses could be effective in treating community-acquired pneumonia.